• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Dyax Corp. (DYAX) - Financial and Strategic SWOT Analysis Review

  • ID: 1291955
  • May 2015
  • 58 pages
  • GlobalData

FEATURED COMPANIES

  • CSL Behring
  • Genentech, Inc.
  • Novo Nordisk A/S
  • Pharming Group N.V.
  • Shire Plc
  • ViroPharma Incorporated
  • MORE

Dyax Corp. (DYAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • CSL Behring
  • Genentech, Inc.
  • Novo Nordisk A/S
  • Pharming Group N.V.
  • Shire Plc
  • ViroPharma Incorporated
  • MORE

List of Tables
List of Figures
Section 1 - About the Company
Dyax Corp. - Key Facts
Dyax Corp. - Key Employees
Dyax Corp. - Key Employee Biographies
Dyax Corp. - Major Products and Services
Dyax Corp. - Pharmaceutical Pipeline Products Data
Dyax Corp., Pipeline Products by Therapy Area
Dyax Corp., Pipeline Products by Development Phase
Dyax Corp. - Medical Equipment Pipeline Products Data
Dyax Corp. Pipeline Products by Equipment Type
Dyax Corp. Pipeline Products by Development Stage
Dyax Corp. - History
Dyax Corp. - Company Statement
Dyax Corp. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Dyax Corp. - Business Description
Dyax Corp. - Corporate Strategy
Dyax Corp. - SWOT Analysis
SWOT Analysis - Overview
Dyax Corp. - Strengths
Strength - Lead Product: Kalbitor
Strength - Licensing and Funded Research Program
Dyax Corp. - Weaknesses
Weakness - History of Losses
Dyax Corp. - Opportunities
Opportunity - Increasing Healthcare Expenditure in the US
Opportunity - Orphan Drug Designation: Kalbitor
Opportunity - Emerging Markets
Dyax Corp. - Threats
Threat - Dependence on Third Party Manufacturers
Threat - Competition and Technological Changes
Threat - Stringent Regulations
Dyax Corp. - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Dyax Corp., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Dyax Corp., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Dyax Corp., Medical Equipment, Deals By Year, 2009 to YTD 2015
Dyax Corp., Medical Equipment, Deals By Type, 2009 to YTD 2015
Dyax Corp., Recent Deals Summary
Section 5 - Company’s Recent Developments
Apr 29, 2015: Dyax Announces First Quarter 2015 Financial Results
Feb 24, 2015: Dyax Announces Fourth Quarter and Full Year 2014 Financial Results
Feb 18, 2015: Dyax to Participate in Upcoming Investor Conferences
Feb 04, 2015: Dyax to Participate in the Leerink Partners 2015 Global Healthcare Conference
Dec 03, 2014: Dyax to Participate in the 25th Annual Oppenheimer Healthcare Conference
Oct 28, 2014: Dyax Announces Third Quarter 2014 Financial Results
Sep 25, 2014: Dyax to Participate in the Leerink Partners Rare Disease Roundtable
Jul 29, 2014: Dyax Announces Second Quarter 2014 Financial Results
Apr 30, 2014: Dyax Announces First Quarter 2014 Financial Results
Apr 16, 2014: Dyax Announces Appointment of Todd Bazemore as Chief Commercial Officer
Section 6 - Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Dyax Corp., Key Facts
Dyax Corp., Key Employees
Dyax Corp., Key Employee Biographies
Dyax Corp., Major Products and Services
Dyax Corp., Number of Pipeline Products by Therapy Area
Dyax Corp., Number of Pipeline Products by Development Stage
Dyax Corp., Pipeline Products By Therapy Area and Development Phase
Dyax Corp. Number of Pipeline Products by Equipment Type
Dyax Corp. Pipeline Products by Equipment Type
Dyax Corp. Number of Pipeline Products by Development Stage
Dyax Corp. Pipeline Products by Development Stage
Dyax Corp., History
Dyax Corp., Subsidiaries
Dyax Corp., Key Competitors
Dyax Corp., Ratios based on current share price
Dyax Corp., Annual Ratios
Dyax Corp., Interim Ratios
Dyax Corp., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Dyax Corp., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Dyax Corp., Medical Equipment, Deals By Year, 2009 to YTD 2015
Dyax Corp., Medical Equipment, Deals By Type, 2009 to YTD 2015
Dyax Corp., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Dyax Corp., Pipeline Products by Therapy Area
Dyax Corp., Pipeline Products by Development Phase
Dyax Corp. Pipeline Products by Equipment Type
Dyax Corp. Pipeline Products by Development Stage
Dyax Corp., Performance Chart (2010 - 2014)
Dyax Corp., Ratio Charts
Dyax Corp., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Dyax Corp., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Dyax Corp., Medical Equipment, Deals By Year, 2009 to YTD 2015
Dyax Corp., Medical Equipment, Deals by Type, 2009 to YTD 2015

Note: Product cover images may vary from those shown

XOMA Ltd.
BioInvent International AB
Novo Nordisk A/S
Shire Plc
ViroPharma Incorporated
Genentech, Inc.
Pharming Group N.V.
CSL Behring

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Grifols, S.A. Takeda Pharmaceutical Company Limited Alexion Pharmaceuticals Teva Pharmaceutical Industries Ltd. Endo International Plc. Essilor International S.A.